XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs... Show more
a developer of therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GAAHX | 18.60 | 0.40 | +2.20% |
| GMO Resources R6 | |||
| FGIWX | 12.71 | -0.08 | -0.63% |
| Nuveen Global Infrastructure R6 | |||
| BROAX | 21.85 | -0.32 | -1.44% |
| BlackRock Advantage International Inv A | |||
| FGEAX | 25.20 | -0.40 | -1.56% |
| Fidelity Advisor Glbl Capital Apprec A | |||
| CMIRX | 8.23 | -0.14 | -1.67% |
| Conestoga Discovery Institutional | |||
A.I.dvisor indicates that over the last year, XTLB has been loosely correlated with SER. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XTLB jumps, then SER could also see price increases.
| Ticker / NAME | Correlation To XTLB | 1D Price Change % | ||
|---|---|---|---|---|
| XTLB | 100% | -6.67% | ||
| SER - XTLB | 59% Loosely correlated | +1.27% | ||
| BCLI - XTLB | 27% Poorly correlated | -6.78% | ||
| ADTX - XTLB | 27% Poorly correlated | -4.83% | ||
| ANRO - XTLB | 26% Poorly correlated | -1.63% | ||
| BCRX - XTLB | 25% Poorly correlated | -0.29% | ||
More | ||||